What are the standard treatment options for soft tissue sarcoma, and how do you recommend we decide the best...

SarcomaMarch 17, 2026Navis AIExpert Reviewed

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Reviewed by Dr. Chris Apfel, MD/PhD (UCSF)

Question asked:

What are the standard treatment options for soft tissue sarcoma, and how do you recommend we decide the best approach for my specific case?

Standard Treatment Options for Soft Tissue Sarcoma

I'm glad you're asking about this—understanding your treatment options is an important part of your care. Let me explain how doctors typically approach soft tissue sarcoma, then we can talk about what questions to ask your team about YOUR specific situation.

How Oncologists Think About Sarcoma Treatment

According to the NCCN Guidelines for Soft Tissue Sarcoma (Version 1.2025), treatment decisions depend on several key factors:

  • Tumor location (extremity, body wall, head/neck, retroperitoneal, or intra-abdominal)
  • Tumor grade (low-grade vs. high-grade)
  • Tumor size and depth
  • Margin status (how completely the tumor was removed)
  • Whether the cancer has spread (metastatic disease)
  • Your overall health and ability to tolerate treatment

General Treatment Approaches That Exist

Doctors typically use a multimodal approach, meaning a combination of treatments:

1. Surgery

  • Removing the tumor with adequate margins (surrounding healthy tissue) is often the foundation of treatment
  • The goal is complete removal while preserving function and minimizing disability
  • NCCN Guidelines emphasize that all patients should be evaluated and treated by a multidisciplinary team with expertise in sarcoma

2. Radiation Therapy

Radiation can be used in several ways:

  • Neoadjuvant radiation (before surgery): Shrinks the tumor to make surgery easier
  • Adjuvant radiation (after surgery): Reduces the risk of local recurrence
  • Definitive radiation: For patients who cannot have surgery
  • SBRT (Stereotactic Body Radiation Therapy): Commonly used for metastatic tumors in the lungs, liver, bone, and other sites

According to NCCN Guidelines, radiation doses typically range from 50-66 Gy depending on margin status and other factors.

3. Systemic Therapy (Chemotherapy and Targeted Drugs)

For high-grade or metastatic sarcomas, chemotherapy may be recommended. The NCCN Guidelines list several preferred regimens including:

  • Doxorubicin-based chemotherapy (often combined with other drugs)
  • Ifosfamide-based regimens
  • Targeted therapies (for specific sarcoma subtypes with known mutations)
  • Immunotherapy (for certain histologies like angiosarcoma)

4. Interventional Oncology (for Metastatic Disease)

For sarcomas that have spread to the liver or other organs:

  • Transarterial chemoembolization (TACE): NCCN Guidelines note this "has been shown to increase overall survival in sarcoma patients with liver metastases"
  • Ablation procedures (cryoablation, radiofrequency ablation)
  • Surgical resection of metastases when feasible

Why Your Specific Case Matters

However, YOUR specific situation requires your doctor's evaluation. The right approach for you depends on:

  • Your exact sarcoma subtype (liposarcoma, leiomyosarcoma, synovial sarcoma, etc.)
  • Whether you have metastatic disease
  • Your tumor's genetic characteristics (biomarkers)
  • Your age, overall health, and personal preferences
  • What treatments you may have already received

Questions to Ask Your Oncology Team

To help guide shared decision-making about YOUR case, consider asking:

  1. "What is my sarcoma subtype, grade, and stage? What do these mean for my prognosis and treatment options?"

  2. "Based on my specific tumor characteristics, which treatment approach do you recommend, and why? What are the pros and cons of this approach?"

  3. "Should I have surgery, radiation, chemotherapy, or a combination? In what order would you recommend them?"

  4. "What are the potential side effects of the treatment you're recommending, and how can we manage them?"

  5. "Are there any clinical trials available for my specific sarcoma subtype that I should consider?"

  6. "How will we monitor my response to treatment, and what imaging or tests will you use?"

  7. "If my tumor doesn't respond as expected, what are my options?"

Key Principle from NCCN Guidelines

The NCCN Guidelines emphasize: "All patients should be evaluated and treated by a multidisciplinary team with expertise and experience in sarcoma." This means your care should involve surgeons, medical oncologists, radiation oncologists, and radiologists who specialize in sarcoma—not just general cancer specialists.


This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

This is general information.

Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.

Get guidance specific to your case

This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: